Euglycemic Diabetic Ketoacidosis Due to SGLT2 Inhibitor in a Patient With Gitelman Syndrome: A Therapeutic Dilemma

Euglycemic diabetic ketoacidosis (DKA) is a rarely reported side effect of sodium-glucose cotransporter-2 inhibitor (SGLT2i) empagliflozin. A 51-year-old female with Gitelman syndrome and type 2 diabetes mellitus (DM) presented with abdominal pain after a recent hospitalization for acute pancreatiti...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Taha, Karimi, Hussain, Hegde, Vishwajit, Lodhi, Samra Haroon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636190/
https://www.ncbi.nlm.nih.gov/pubmed/34873512
http://dx.doi.org/10.7759/cureus.19169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636190/
https://www.ncbi.nlm.nih.gov/pubmed/34873512
http://dx.doi.org/10.7759/cureus.19169

Ejemplares similares